Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain and muscle ARNT-like protein 1 (BMAL1), encoded by the ARNTL gene, is a master transcription factor and a core component of the mammalian circadian clock (UniProt: P49759). It functions by forming a heterodimer with CLOCK or NPAS2, which binds to E-box sequences in the promoter regions of clock-controlled genes to initiate their transcription (PubMed: 24037396). This molecular oscillator regulates a wide array of physiological processes, including glucose metabolism, lipid homeostasis, and immune responses. Dysregulation of BMAL1 is strongly associated with metabolic disorders, such as obesity and type 2 diabetes, as well as accelerated aging and various forms of cancer (PubMed: 30635457). In the context of pharmacology, BMAL1 is an emerging therapeutic target; small molecules like the natural flavonoid Nobiletin have been shown to enhance its activity, offering potential treatments for metabolic and neurodegenerative diseases (PubMed: 27090315). Additionally, the BMAL1-dependent clock machinery is being explored in chronotherapy to optimize the timing of drug delivery and minimize toxicity (PubMed: 29107506).
BMAL1 functions by forming a heterodimer with CLOCK or NPAS2 to bind E-box elements (5'-CACGTG-3') in the promoters of clock-controlled genes, thereby driving the rhythmic expression of the molecular clock's primary and secondary feedback loops (PubMed: 24037396).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain and muscle ARNT-like protein 1 (BMAL1) (BMAL1).